CPHI [CHINA PHARMAS,] SC 13G/A: cphi_1.txt 1 13G/A
[cphi_1.txt 1 13G/A]
CYOU [Changyou.com] SC 13G/A: CUSIPNo. 15911M107 1. Names of Reporting Persons STYLE=”font-family:Times
[CUSIPNo. 15911M107 1. Names of Reporting Persons STYLE="font-family:Times New Roman" SIZE="3">Prominence Investments 2. Check the Appropriate Box if a Member of a (See Instructions) (a) 3. SEC Use Only 4. Citizenship or Place of Organization British Virgin Islands Numberof Shares Beneficially Ownedby Each Reporting Person With 5. Sole Voting Power]
ZA [ZUOAN FASHION] SC 13G/A: (Original Filing)
[Michael Self 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP £ (a) £ (b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0]
ZA [ZUOAN FASHION] SC 13G/A: Michael Self 2. CHECK THE APPROPRIATE BOX IF
[Michael Self 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP £ (a) £ (b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0]
IDI [IDI] SC 13G/A: (Original Filing)
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 subject to the liabilities]
CHA [CHINA TELECOM] SC 13G/A: (Original Filing)
[CUSIP NO. 169426103 13G Page 2 of 13 1. NAMES OF REPORTING PERSONS.]
WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)
[SCHEDULE 13G (Amendment No. 3)* WuXi PharmaTech (Cayman) Inc. (Name of Issuer) Ordinary Shares, par value $0.02 per share (Title of Class of Securities) 929352102 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page shall be filled out for a]
WX [WuXi PharmaTech (Cayman)] SC 13G/A: SCHEDULE 13G (Amendment No. 3)* WuXi PharmaTech (Cayman)
[SCHEDULE 13G (Amendment No. 3)* WuXi PharmaTech (Cayman) Inc. (Name of Issuer) Ordinary Shares, par value $0.02 per share (Title of Class of Securities) 929352102 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page shall be filled out for a]
MR [Mindray Medical International] SC 13G/A: CUSIP No. 602675100HEDULE 13G Page 2 of 8
[CUSIP No. 602675100HEDULE 13G Page 2 of 8 Pages 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OFOVE PERSONS (ENTITIES ONLY) Xu Hang 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A x (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Peoples Republic of China] [Joint Filingreement Xu Hang New Dragon (No. 12) Investments Limited Xu Hang Director New Phoenix Limited Jian Yao Sole Shareholder JOINT FILINGREEMENT d297266dex99a.htm 2 EX-99.(A)]
CSIQ [Canadian Solar] SC 13G/A: (Original Filing)
[Dated: February 10, 2012 Columbia Wanger Asset Management, LLC Bruce H. Lauer Chief Operating Officer Columbia Acorn Trust Bruce H. Lauer Vice President, Treasurer and Secretary EX-99.1 2 d296949dex991.htm JOINT FILING AGREEMENT] [1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY): Columbia Wanger Asset Management, LLC 04-3519872 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) ¨ ¨ (a) 3]
